Sides

Following the start of the US-Israel war on Iran,, the first match of the Iranian league was played last week.

Iranian clubs have been confirmed to play at neutral venues against their Qatari and United Arab Emirates opponents following the draw for the group stage of the Asian Champions League Elite.

Matches in the Asian Football Confederation’s (AFC) premier event, which was drawn on Tuesday, begin on September 14.

Tehran’s Esteghlal and Tabriz-based Tractor will face UAE sides Al Ain, Al Wasl and Shabab Al-Ahli, and Qatari clubs Al Gharafa, Al Sadd and Al Shamal, despite the ongoing conflict in the region.

Esteghlal and Tractor avoided the heavily favoured Saudi Arabian contingent.

Since the United States and Israel attacked Iran in February, Iran has struck targets in Qatar and the UAE, saying it is retaliating for allowing US bases to be used for strikes.

Iran’s neighbours have implored Tehran to stop firing at them. On Sunday, Iran claimed three of its pilots who went missing in March were being held in Qatar, though Doha denied the charge.

Iran’s domestic league was suspended in February as attacks began but returned last weekend with one match behind closed doors and others under capacity restrictions.

The AFC Elite features two 16-team regional zones. In the west, Saudi Arabia has five representatives, including Jeddah’s Al-Ahli, which is aiming to become the first club to win three straight Champions League titles. Coach Matthias Jaissle left this month to take over English Premier League side Newcastle.

Riyadh rival Al-Hilal is seeking a fifth title, while Cristiano Ronaldo leads Al-Nassr back into the competition after winning the Saudi Pro League in May.

In the east, Japan reached the final in the past two editions, with Kawasaki Frontale and Machida Zelvia losing to Al-Ahli, though neither has qualified this year.

Gamba Osaka won in 2008, and South Korea also supplies two former champions: Jeonbuk Hyundai Motors, aiming for a third crown, and Pohang Steelers, looking for a fourth.

The top eight from each group advance to the round of 16. From the quarterfinals onward, all matches will be played in Saudi Arabia, with the final set for May 1.

President Trump’s goal of ending gender-affirming care is not improper and cannot be the basis for quashing a subpoena issued by the Justice Department against a provider of medical treatment for transgender youth, a divided federal appeals court ruled Friday.

The Justice Department announced last year that it had issued more than 20 subpoenas to doctors and clinics that provide gender-affirming care as part of an effort to investigate healthcare fraud. Federal judges have quashed many of the subpoenas as illegitimate efforts to intimidate providers into ending care.

In a 2-1 decision, a panel of the 9th U.S. Circuit Court of Appeals said the efficacy and long-term risks of the treatments are “uncertain,” and the president has the power to align the Justice Department’s enforcement priorities with his broader policy goals.

“Every President has law enforcement priorities, just as every President has signature policies (often, the former are components of the latter),” wrote Judge Carlos Bea.

Bea, a nominee of Republican President George W. Bush, was joined in the opinion by Daniel Bress, a Trump nominee. They reversed a ruling that quashed the subpoena against telemedicine provider QueerDoc, sending the case back to the district court to consider other arguments.

The subpoena seeks QueerDoc’s personnel files, billing documents, communications with drug manufacturers and records of patients who were prescribed puberty blockers or hormone therapy, among other information, according to the 9th Circuit decision.

American Civil Liberties Union attorney Adrien Leavitt, who represented Washington state-based QueerDoc, said the ACLU would continue fighting the subpoena in district court. QueerDoc has also argued the subpoena is overbroad and burdensome. The Justice Department has said it has reason to believe the company may be misleading people about puberty blockers and hormones.

“We’re ready to continue defending one of the most fundamental principles of healthcare: every patient’s right to confidential medical care,” Leavitt said in a statement.

He said the San Francisco-based 9th Circuit was the first appeals court to weigh in on the subpoenas.

Trump has signed one executive order defining sex as only male or female — and as unchangeable — and another that seeks to end federal funding of the care for patients under 19. The latter order also directs the Justice Department to “prioritize investigations” into violations of a drug safety law by “any entity that may be misleading the public about long-term side effects of chemical and surgical mutilation.”

Gender-affirming care includes a range of medical and mental health services to support a person’s gender identity, including when it’s different from the sex they were assigned at birth. It encompasses counseling, medications that block puberty and hormone therapy to produce physical changes as well as surgeries to transform chests and genitals, though those are rare for minors.

Most major medical groups say access to the treatment is important for those with gender dysphoria and see gender as existing along a spectrum.

The 9th Circuit majority called discussion around gender-affirming care “an unsettled scientific debate” and said the Trump administration could also justify its opposition to the treatment on ethical or philosophical grounds.

Thanawala writes for the Associated Press.